IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,965,253 | +143.3% | 75,375 | +50.4% | 0.01% | +150.0% |
| Q1 2023 | $1,218,933 | -8.3% | 50,100 | -19.3% | 0.00% | -33.3% |
| Q4 2022 | $1,329,561 | +53.7% | 62,100 | +28.8% | 0.00% | +50.0% |
| Q3 2022 | $865,000 | -69.7% | 48,200 | -83.7% | 0.00% | -33.3% |
| Q2 2022 | $2,853,000 | -54.9% | 296,549 | -21.2% | 0.00% | -40.0% |
| Q1 2022 | $6,332,000 | +108.7% | 376,233 | +106.9% | 0.01% | +150.0% |
| Q4 2021 | $3,034,000 | +96.6% | 181,801 | +91.3% | 0.00% | +100.0% |
| Q3 2021 | $1,543,000 | – | 95,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |